
Novavax COVID-19 vaccine gets approval for use in Canada
BNN Bloomberg
The Novavax COVID-19 vaccine has been approved for use in Canada.
The Novavax COVID-19 vaccine has been approved for use in Canada.
The vaccine, which is protein-based, is the first of its kind to get approval in the country.
Experts say a non-mRNA vaccine could win over some vaccine-hesitant people who have still not received a dose of a COVID-19 vaccine.
The U.S. company Novavax Inc. submitted its package for approval to Health Canada last November.
The Novavax shots have already been cleared for use in other countries, including Britain, Europe, Australia and Singapore.
Ottawa also signed a deal last year to produce the Novavax vaccine in Canada and a manufacturing plant was constructed in Montreal.

A key question hangs over the Federal Reserve’s two-day meeting that ends Wednesday: Will central bank policymakers still reduce short-term interest rates this year, now that the Iran war has sent oil prices higher and gas prices spiking? Or will they have to stand pat for months to see how the conflict plays out?

Oil tankers are crossing the Strait of Hormuz and Iran’s actions to choke traffic through the shipping route have not hurt the U.S. economy, White House economic adviser Kevin Hassett told CNBC on Tuesday, reiterating the Trump administration’s position that the war should be over in weeks, not months.











